Dr von Dadelszen is a clinician-scientist, with particular interest in translational research related to the hypertensive disorders of pregnancy, especially pre-eclampsia.


Payne B, Hodgson S, Hutcheon J, Joseph K, Li J, Lee T, Magee L, Qu Z, von Dadelszen P. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission. BJOG 2013;120(1):113-118 (PMID: 23078362). [Role: underlying hypothesis, funding application (PI), study design, data analysis and interpretation, manuscript preparation; funding: CIHR, MSFHR, CFRI, WHO, Preeclampsia Foundation, FIGO, US AID].


CHIPS (Control of Hypertension in Pregnancy Study)
PI: LA Magee Co: P von Dadelszen

Canadian Institutes of Health Research (CIHR)
Investigating severe maternal morbidity
PI: Joseph, KS Co:

Canadian Institutes of Health Research (CIHR)
PI: Laura Magee Co:

Bill & Melinda Gates Foundation

PI: Peter von Dadelszen Co: